CD8A and neoplasm: The killing effects of drug combinations were compromised when utilizing anti-CD8α antibody to deplete CD8+ T cells in immune intact mice, suggesting drug combinations treatment induces the generation and expansion of cytotoxic CD8+ T cells, which are responsible for the inhibition of tumor growth.